
Oncology NEWS International
- Oncology NEWS International Vol 18 No 10
- Volume 18
- Issue 10
Posaconazole reduces infection in AML patients
The incidence of pneumonia and invasive pulmonary aspergillosis in acute myeloid leukemia patients was reduced when they were given posaconazole (Noxafil) as prophylaxis.
The incidence of pneumonia and invasive pulmonary aspergillosis in acute myeloid leukemia patients was reduced when they were given posaconazole (Noxafil) as prophylaxis.
According to a study presented at the 2009 Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco, the number of febrile days, incidence rates of invasive fungal diseases and aspergillosis, and duration of hospitalization decreased significantly (abstract 1052).
Articles in this issue
over 16 years ago
Cancer, not HPV vaccination, hastened death of UK girlover 16 years ago
Obesity hinders treatment in pediatric leukemiaover 16 years ago
Global report warns of escalating cancer rateover 16 years ago
New class of alpha emitters takes aim at bone metastasesover 16 years ago
Who's Newsover 16 years ago
Stop and smell the volatile organic compounds in lung caover 16 years ago
Proton therapy report advises cautionNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


































